Wencong Han
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wencong Han has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Zheng Zhang
4 shared publicationsGuanpeng Han
Peking University First Hospital, China; Peking University, China; National Urological Cancer Center, China
2 shared publicationsKunlin Yang
Peking University First Hospital, China; Peking University, China; National Urological Cancer Center, China
2 shared publicationsQi Shen
Department of Urology, Peking University First Hospital, Beijing, China
2 shared publicationsZhenyu Li
Peking University First Hospital, China; Peking University, China; National Urological Cancer Center, China
2 shared publicationsZhihua Li
Peking University First Hospital, China; Peking University, China; National Urological Cancer Center, China
2 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Elsevier in Asian Journal of Surgery
Concomitant renal pelvis and urinary bladder urothelial carcinomas in crossed nonfused renal ectopia: A case report
- 21 October 2026
- Published by Elsevier in Asian Journal of Surgery
Open AccessConcomitant renal pelvis and urinary bladder urothelial carcinomas in crossed nonfused renal ectopia: A case report
- Open Access
- 1 June 2026
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 52 (3)
Robotic-Assisted Laparoscopic Buccal Mucosal Graft Ureteroplasty and Ureteral Reimplantation for Repair of Complex Ureteral Strictures Using the Modular Carina™ System
Purpose: Multifocal ureteral strictures pose significant challenges for reconstructive surgery due to their segmental distribution and the need to preserve the ureteral blood supply (1, 2). Robotic-assisted surgery, owing to its precision and minimally invasive advantages, has increasingly become a preferred approach (3). Although the da Vinci surgical system has long dominated this field, several novel robotic platforms have recently emerged with comparable safety and efficacy (4, 5). This study reports our experience with robotic-assisted laparoscopic buccal mucosal graft ureteroplasty combined with ureteral reimplantation for complex ureteral stricture repair using the modular Carina™ robotic surgical system. Materials and Methods: A 32-year-old man presented with a one-month history of flank pain and was found to have both proximal and distal ureteral strictures. Using the modular Carina™ robotic system, the procedure was performed as follows: dissection of the proximal stricture, longitudinal ureterotomy, posterior augmented anastomosis, harvesting of buccal mucosa for ventral onlay grafting; followed by dissection of the distal ureteral stricture and bladder wall and completion of a side-to-side ureterovesical anastomosis. Results: The procedure was completed successfully without conversion, with a total operative time of 272 minutes. The patient was discharged on postoperative day 7. Histopathological examination revealed granulomatous inflammation, and anti-tuberculosis therapy was initiated. The double-J stent and nephrostomy tube were removed 2 months postoperatively. During an 8-month follow-up, the patient's symptoms resolved, imaging demonstrated improvement of hydronephrosis, renal function remained stable, and no postoperative complications were observed. Conclusions: Robotic-assisted reconstructive surgery for complex ureteral strictures using the modular Carina™ robotic system is technically feasible. However, larger studies with longer follow-up are required to validate these preliminary findings.
- 1 June 2026
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 52 (3)
Open AccessRobotic-Assisted Laparoscopic Buccal Mucosal Graft Ureteroplasty and Ureteral Reimplantation for Repair of Complex Ureteral Strictures Using the Modular Carina™ System
Purpose: Multifocal ureteral strictures pose significant challenges for reconstructive surgery due to their segmental distribution and the need to preserve the ureteral blood supply (1, 2). Robotic-assisted surgery, owing to its precision and minimally invasive advantages, has increasingly become a preferred approach (3). Although the da Vinci surgical system has long dominated this field, several novel robotic platforms have recently emerged with comparable safety and efficacy (4, 5). This study reports our experience with robotic-assisted laparoscopic buccal mucosal graft ureteroplasty combined with ureteral reimplantation for complex ureteral stricture repair using the modular Carina™ robotic surgical system. Materials and Methods: A 32-year-old man presented with a one-month history of flank pain and was found to have both proximal and distal ureteral strictures. Using the modular Carina™ robotic system, the procedure was performed as follows: dissection of the proximal stricture, longitudinal ureterotomy, posterior augmented anastomosis, harvesting of buccal mucosa for ventral onlay grafting; followed by dissection of the distal ureteral stricture and bladder wall and completion of a side-to-side ureterovesical anastomosis. Results: The procedure was completed successfully without conversion, with a total operative time of 272 minutes. The patient was discharged on postoperative day 7. Histopathological examination revealed granulomatous inflammation, and anti-tuberculosis therapy was initiated. The double-J stent and nephrostomy tube were removed 2 months postoperatively. During an 8-month follow-up, the patient's symptoms resolved, imaging demonstrated improvement of hydronephrosis, renal function remained stable, and no postoperative complications were observed. Conclusions: Robotic-assisted reconstructive surgery for complex ureteral strictures using the modular Carina™ robotic system is technically feasible. However, larger studies with longer follow-up are required to validate these preliminary findings.
- Open Access
- 29 January 2026
- Published by SAGE Publications in Therapeutic Advances in Endocrinology and Metabolism
- Vol. 17
Efficacy and safety of pralsetinib in multiple endocrine neoplasia type 2-associated pheochromocytoma: a case report
A 34-year-old male developed bilateral recurrent pheochromocytomas 10 years after laparoscopic adrenal-sparing surgery for pheochromocytomas. Based on his clinical manifestations and germline REarranged during Transfection (RET) variant, the patient was ultimately diagnosed with multiple endocrine neoplasia type 2B. Based on drug susceptibility testing results from organoid-guided precision therapy, the patient underwent secondary adrenalectomy for the right lesion and received oral pralsetinib to control the left ones. Over 16 months of pralsetinib therapy, we found that the patient achieved sustained therapeutic benefits, specifically characterized by symptomatic relief, significant reduction in hormone levels, and shrinkage of the left adrenal masses. These findings indicate that pralsetinib is effective and safe for treating pheochromocytomas associated with RET missense mutation, but further clinical practices are warranted to confirm its efficacy and safety profile.
- 29 January 2026
- Published by SAGE Publications in Therapeutic Advances in Endocrinology and Metabolism
- Vol. 17
Open AccessEfficacy and safety of pralsetinib in multiple endocrine neoplasia type 2-associated pheochromocytoma: a case report
A 34-year-old male developed bilateral recurrent pheochromocytomas 10 years after laparoscopic adrenal-sparing surgery for pheochromocytomas. Based on his clinical manifestations and germline REarranged during Transfection (RET) variant, the patient was ultimately diagnosed with multiple endocrine neoplasia type 2B. Based on drug susceptibility testing results from organoid-guided precision therapy, the patient underwent secondary adrenalectomy for the right lesion and received oral pralsetinib to control the left ones. Over 16 months of pralsetinib therapy, we found that the patient achieved sustained therapeutic benefits, specifically characterized by symptomatic relief, significant reduction in hormone levels, and shrinkage of the left adrenal masses. These findings indicate that pralsetinib is effective and safe for treating pheochromocytomas associated with RET missense mutation, but further clinical practices are warranted to confirm its efficacy and safety profile.
- Open Access
- 1 January 2026
- Vol. 52 (3)
Robotic-Assisted Laparoscopic Buccal Mucosal Graft Ureteroplasty and Ureteral Reim-plantation for Repair of Complex Ureteral Strictures Using the Modular Carina™ System.
Multifocal ureteral strictures pose significant challenges for reconstructive surgery due to their segmental distribution and the need to preserve the ureteral blood supply (1, 2). Robotic-assisted surgery, owing to its precision and minimally invasive advantages, has increasingly become a preferred approach (3). Although the da Vinci surgical system has long dominated this field, several novel robotic platforms have recently emerged with comparable safety and efficacy (4, 5). This study reports our experience with robotic-assisted laparoscopic buccal mucosal graft ureteroplasty combined with ureteral reimplantation for complex ureteral stricture repair using the modular Carina™ robotic surgical system. A 32-year-old man presented with a one-month history of flank pain and was found to have both proximal and distal ureteral strictures. Using the modular Carina™ robotic system, the procedure was performed as follows: dissection of the proximal stricture, longitudinal ureterotomy, posterior augmented anastomosis, harvesting of buccal mucosa for ventral onlay grafting; followed by dissection of the distal ureteral stricture and bladder wall and completion of a side-to-side ureterovesical anastomosis. The procedure was completed successfully without conversion, with a total operative time of 272 minutes. The patient was discharged on postoperative day 7. Histopathological examination revealed granulomatous inflammation, and anti-tuberculosis therapy was initiated. The double-J stent and nephrostomy tube were removed 2 months postoperatively. During an 8-month follow-up, the patient's symptoms resolved, imaging demonstrated improvement of hydronephrosis, renal function remained stable, and no postoperative complications were observed. Robotic-assisted reconstructive surgery for complex ureteral strictures using the modular Carina™ robotic system is technically feasible. However, larger studies with longer follow-up are required to validate these preliminary findings.
- 1 January 2026
- Vol. 52 (3)
Open AccessRobotic-Assisted Laparoscopic Buccal Mucosal Graft Ureteroplasty and Ureteral Reim-plantation for Repair of Complex Ureteral Strictures Using the Modular Carina™ System.
Multifocal ureteral strictures pose significant challenges for reconstructive surgery due to their segmental distribution and the need to preserve the ureteral blood supply (1, 2). Robotic-assisted surgery, owing to its precision and minimally invasive advantages, has increasingly become a preferred approach (3). Although the da Vinci surgical system has long dominated this field, several novel robotic platforms have recently emerged with comparable safety and efficacy (4, 5). This study reports our experience with robotic-assisted laparoscopic buccal mucosal graft ureteroplasty combined with ureteral reimplantation for complex ureteral stricture repair using the modular Carina™ robotic surgical system. A 32-year-old man presented with a one-month history of flank pain and was found to have both proximal and distal ureteral strictures. Using the modular Carina™ robotic system, the procedure was performed as follows: dissection of the proximal stricture, longitudinal ureterotomy, posterior augmented anastomosis, harvesting of buccal mucosa for ventral onlay grafting; followed by dissection of the distal ureteral stricture and bladder wall and completion of a side-to-side ureterovesical anastomosis. The procedure was completed successfully without conversion, with a total operative time of 272 minutes. The patient was discharged on postoperative day 7. Histopathological examination revealed granulomatous inflammation, and anti-tuberculosis therapy was initiated. The double-J stent and nephrostomy tube were removed 2 months postoperatively. During an 8-month follow-up, the patient's symptoms resolved, imaging demonstrated improvement of hydronephrosis, renal function remained stable, and no postoperative complications were observed. Robotic-assisted reconstructive surgery for complex ureteral strictures using the modular Carina™ robotic system is technically feasible. However, larger studies with longer follow-up are required to validate these preliminary findings.
- 9 October 2025
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 34 (2) , 550-554
SMARCB1 (INI-1)-Deficient Myoepithelioma-Like Tumor in the Perineal Region of a Male Patient: A Case Report
SMARCB1/INI1 is a critical tumor suppressor gene involved in chromatin remodeling, and its loss of expression is linked to various malignancies. We report a rare case of SMARCB1-deficient myoepithelioma-like tumors in the male perineum. A 72-year-old man presented with a progressively enlarging perineal mass, accompanied by urinary difficulties and increased frequency. Imaging with positron emission tomography/computed tomography revealed an ill-defined mass with increased tracer uptake, suggesting malignancy. Histological examination showed myoepithelial differentiation, and immunohistochemistry confirmed the loss of SMARCB1 expression. The tumor exhibited an indolent course with no evidence of metastasis or recurrence during an 8-month follow-up period. This report highlights a rare presentation of SMARCB1-deficient myoepithelioma-like tumors in the male perineum and provides valuable insights into their diagnosis and clinical behavior.
- 9 October 2025
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 34 (2) , 550-554
SMARCB1 (INI-1)-Deficient Myoepithelioma-Like Tumor in the Perineal Region of a Male Patient: A Case Report
SMARCB1/INI1 is a critical tumor suppressor gene involved in chromatin remodeling, and its loss of expression is linked to various malignancies. We report a rare case of SMARCB1-deficient myoepithelioma-like tumors in the male perineum. A 72-year-old man presented with a progressively enlarging perineal mass, accompanied by urinary difficulties and increased frequency. Imaging with positron emission tomography/computed tomography revealed an ill-defined mass with increased tracer uptake, suggesting malignancy. Histological examination showed myoepithelial differentiation, and immunohistochemistry confirmed the loss of SMARCB1 expression. The tumor exhibited an indolent course with no evidence of metastasis or recurrence during an 8-month follow-up period. This report highlights a rare presentation of SMARCB1-deficient myoepithelioma-like tumors in the male perineum and provides valuable insights into their diagnosis and clinical behavior.
- Open Access
- 9 May 2025
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (10) , 6485-6486
Robot-assisted laparoscopic partial nephrectomy combined with radical prostatectomy: A case report
- 9 May 2025
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (10) , 6485-6486
Open AccessRobot-assisted laparoscopic partial nephrectomy combined with radical prostatectomy: A case report